MENU
+Compare
NVNO
Stock ticker: NASDAQ
AS OF
Dec 12 closing price
Price
$0.33
Change
-$0.02 (-5.71%)
Capitalization
6.62M

NVNO enVVeno Medical Corp Forecast, Technical & Fundamental Analysis

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease... Show more

NVNO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for NVNO with price predictions
Dec 11, 2025

NVNO's Stochastic Oscillator remains in oversold zone for 2 days

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NVNO's RSI Oscillator exited the oversold zone, of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 11, 2025. You may want to consider a long position or call options on NVNO as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NVNO just turned positive on November 28, 2025. Looking at past instances where NVNO's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NVNO advanced for three days, in of 251 cases, the price rose further within the following month. The odds of a continued upward trend are .

NVNO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVNO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NVNO entered a downward trend on December 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.225) is normal, around the industry mean (63.323). P/E Ratio (0.000) is within average values for comparable stocks, (37.320). NVNO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.632). NVNO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (0.000) is also within normal values, averaging (36.682).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NVNO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NVNO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
NVNO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

NVNO is expected to report earnings to rise 21.74% to -28 cents per share on February 26

enVVeno Medical Corp NVNO Stock Earnings Reports
Q4'25
Est.
$-0.28
Q3'25
Beat
by $0.07
Q2'25
Missed
by $0.03
Q1'25
Beat
by $0.12
Q4'24
Est.
$-0.35
The last earnings report on November 28 showed earnings per share of -23 cents, beating the estimate of -30 cents. With 248.83K shares outstanding, the current market capitalization sits at 6.62M.
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
70 Doppler
Phone
+1 949 261-2900
Employees
31
Web
https://www.envveno.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UPWK21.921.44
+7.03%
Upwork
AMN16.270.30
+1.88%
AMN Healthcare Services
PKG205.302.68
+1.32%
Packaging Corp
MX2.93-0.02
-0.68%
Magnachip Semiconductor Corp
ORKT1.16-0.18
-13.43%
Orangekloud Technology Inc

NVNO and Stocks

Correlation & Price change

A.I.dvisor tells us that NVNO and HBIO have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVNO and HBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVNO
1D Price
Change %
NVNO100%
+1.32%
HBIO - NVNO
31%
Poorly correlated
-2.80%
DHR - NVNO
31%
Poorly correlated
+0.85%
RGEN - NVNO
30%
Poorly correlated
-1.31%
TWST - NVNO
30%
Poorly correlated
-2.01%
NOTV - NVNO
28%
Poorly correlated
-4.48%
More

Groups containing NVNO

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVNO
1D Price
Change %
NVNO100%
+1.32%
Medical/Nursing Services
industry (214 stocks)
17%
Poorly correlated
-1.24%
Health Services
industry (421 stocks)
-1%
Poorly correlated
-0.70%